Haw Par (H02) Stock Overview
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
H02 Community Fair Values
See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Haw Par Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$15.53 |
| 52 Week High | S$15.87 |
| 52 Week Low | S$10.98 |
| Beta | 0.22 |
| 1 Month Change | 3.53% |
| 3 Month Change | 7.92% |
| 1 Year Change | 35.28% |
| 3 Year Change | 65.04% |
| 5 Year Change | 43.80% |
| Change since IPO | 631.18% |
Recent News & Updates
Haw Par (SGX:H02) Ticks All The Boxes When It Comes To Earnings Growth
Dec 08Does Haw Par (SGX:H02) Have A Healthy Balance Sheet?
Nov 02Potential Upside For Haw Par Corporation Limited (SGX:H02) Not Without Risk
Sep 19Haw Par (SGX:H02) Ticks All The Boxes When It Comes To Earnings Growth
Jul 28Recent updates
Shareholder Returns
| H02 | SG Pharmaceuticals | SG Market | |
|---|---|---|---|
| 7D | -1.7% | -0.2% | 0.9% |
| 1Y | 35.3% | 12.5% | 21.1% |
Return vs Industry: H02 exceeded the SG Pharmaceuticals industry which returned 12.5% over the past year.
Return vs Market: H02 exceeded the SG Market which returned 21.1% over the past year.
Price Volatility
| H02 volatility | |
|---|---|
| H02 Average Weekly Movement | 2.2% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SG Market | 15.4% |
| 10% least volatile stocks in SG Market | 2.1% |
Stable Share Price: H02 has not had significant price volatility in the past 3 months compared to the SG market.
Volatility Over Time: H02's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Ee Lim Wee | www.hawpar.com |
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties.
Haw Par Corporation Limited Fundamentals Summary
| H02 fundamental statistics | |
|---|---|
| Market cap | S$3.44b |
| Earnings (TTM) | S$250.42m |
| Revenue (TTM) | S$253.05m |
Is H02 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H02 income statement (TTM) | |
|---|---|
| Revenue | S$253.05m |
| Cost of Revenue | S$111.98m |
| Gross Profit | S$141.07m |
| Other Expenses | -S$109.35m |
| Earnings | S$250.42m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.13 |
| Gross Margin | 55.75% |
| Net Profit Margin | 98.96% |
| Debt/Equity Ratio | 0.8% |
How did H02 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/15 01:53 |
| End of Day Share Price | 2025/12/15 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Haw Par Corporation Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
